TruWealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TruWealth Advisors's PFE Position: Q1 2026 in Review
TruWealth Advisors increased its Pfizer (PFE) stake by 0.01% in Q1 2026, buying an estimated $53 and bringing the position to 36,369 shares worth $1.02M. The position accounts for 0.05% of the portfolio, ranked #96.
TruWealth Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.48M in Q4 2021. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- TruWealth Advisors held 36,369 shares of Pfizer worth $1.02M as of Q1 2026.
- TruWealth Advisors bought 2 Pfizer shares in Q1 2026, an estimated $53.
- Pfizer made up 0.05% of TruWealth Advisors's portfolio in Q1 2026, its #96 holding.
- TruWealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- TruWealth Advisors's Pfizer position peaked at $2.48M in Q4 2021.
- 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on TruWealth Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.